252 related articles for article (PubMed ID: 32415030)
1. Parkinsonism with newly diagnosed flare-up rheumatoid arthritis mimicking progressive supranuclear palsy.
Lee KW; Chien CF; Wu MN; Lai CL; Liou LM
Neurol India; 2020; 68(2):481-482. PubMed ID: 32415030
[TBL] [Abstract][Full Text] [Related]
2. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
[TBL] [Abstract][Full Text] [Related]
3. "Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.
Necpál J; Borsek M; Jeleňová B
Neurol Sci; 2021 Dec; 42(12):4927-4936. PubMed ID: 34532773
[TBL] [Abstract][Full Text] [Related]
4. Progressive supra-nuclear palsy: frequency of cardinal extrapyramidal features at first presentation.
Pradhan S; Tandon R
Postgrad Med J; 2015 May; 91(1075):274-7. PubMed ID: 25964368
[TBL] [Abstract][Full Text] [Related]
5. Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson's disease: analysis with [(123)I]IPT single photon emission computed tomography.
Im JH; Chung SJ; Kim JS; Lee MC
J Neurol Sci; 2006 May; 244(1-2):103-9. PubMed ID: 16473371
[TBL] [Abstract][Full Text] [Related]
6. Identification of multiple system atrophy mimicking Parkinson's disease or progressive supranuclear palsy.
Miki Y; Tsushima E; Foti SC; Strand KM; Asi YT; Yamamoto AK; Bettencourt C; Oliveira MCB; De Pablo-Fernández E; Jaunmuktane Z; Lees AJ; Wakabayashi K; Warner TT; Quinn N; Holton JL; Ling H
Brain; 2021 May; 144(4):1138-1151. PubMed ID: 33822892
[TBL] [Abstract][Full Text] [Related]
7. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
[TBL] [Abstract][Full Text] [Related]
8. Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly.
Fernández-Ferreira R; García-Santos RA; Rodríguez-Violante M; López-Martínez C; Becerra-Laparra IK; Torres-Pérez ME
Rev Esp Geriatr Gerontol; 2019; 54(5):251-256. PubMed ID: 31324404
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
[TBL] [Abstract][Full Text] [Related]
10. Compassionate trial of levodopa carbidopa intestinal gel infusion in two patients with progressive supranuclear palsy.
Bhidayasiri R; Jitkritsadakul O; Boonrod N; Rerknimitr R
Clin Neurol Neurosurg; 2014 Jan; 116():1-3. PubMed ID: 24388506
[No Abstract] [Full Text] [Related]
11. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
12. Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
Ondo W; Warrior D; Overby A; Calmes J; Hendersen N; Olson S; Jankovic J
Arch Neurol; 2000 Oct; 57(10):1464-9. PubMed ID: 11030799
[TBL] [Abstract][Full Text] [Related]
13. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
[TBL] [Abstract][Full Text] [Related]
14. The auditory startle response in parkinsonism may reveal the extent but not type of pathology.
Williams DR; Doyle LM; Lees AJ; Brown P
J Neurol; 2008 May; 255(5):628-32. PubMed ID: 18283396
[TBL] [Abstract][Full Text] [Related]
15. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
[TBL] [Abstract][Full Text] [Related]
17. Caribbean parkinsonism and other atypical parkinsonian disorders.
Tolosa E; Calandrella D; Gallardo M
Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S19-26. PubMed ID: 15109583
[TBL] [Abstract][Full Text] [Related]
18. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.
Litvan I; Grimes DA; Lang AE; Jankovic J; McKee A; Verny M; Jellinger K; Chaudhuri KR; Pearce RK
J Neurol; 1999 Sep; 246 Suppl 2():II1-5. PubMed ID: 10525996
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Grabli D
Presse Med; 2017 Mar; 46(2 Pt 1):187-194. PubMed ID: 28233705
[TBL] [Abstract][Full Text] [Related]
20. ["Red flags": when to be alerted and how to explore?].
Tison F
Rev Neurol (Paris); 2010 Oct; 166(10):775-8. PubMed ID: 20817230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
